Lecanemab approval in EU: what should we be ready for?– the EANM perspective

Igor Yakushev; Antoine Verger; Matthias Brendel; Diego Cecchin; Pablo Aguiar Fernandez; Francesco Fraioli; Timo Grimmer; Nelleke Tolboom; Tatjana Traub-Weidinger; Eric Guedj; Donatienne Van Weehaeghe

doi:10.1007/s00259-025-07066-9

Lecanemab approval in EU: what should we be ready for?– the EANM perspective

Igor Yakushev, Antoine Verger, Matthias Brendel, Diego Cecchin, Pablo Aguiar Fernandez, Francesco Fraioli, Timo Grimmer, Nelleke Tolboom, Tatjana Traub-Weidinger, Eric Guedj, Donatienne Van Weehaeghe

Department of Psychiatry and Psychotherapy

Research output: Contribution to journal › Editorial

2 Scopus citations

Original language	English
Journal	European Journal of Nuclear Medicine and Molecular Imaging
DOIs	https://doi.org/10.1007/s00259-025-07066-9
State	Accepted/In press - 2025

Access to Document

10.1007/s00259-025-07066-9

Cite this

@article{fb0c5330ba3c4b609ff301392669889b,

title = "Lecanemab approval in EU: what should we be ready for?– the EANM perspective",

author = "Igor Yakushev and Antoine Verger and Matthias Brendel and Diego Cecchin and Fernandez, \{Pablo Aguiar\} and Francesco Fraioli and Timo Grimmer and Nelleke Tolboom and Tatjana Traub-Weidinger and Eric Guedj and \{Van Weehaeghe\}, Donatienne",

year = "2025",

doi = "10.1007/s00259-025-07066-9",

language = "English",

journal = "European Journal of Nuclear Medicine and Molecular Imaging",

issn = "1619-7070",

publisher = "Springer",

}

TY - JOUR

T1 - Lecanemab approval in EU

T2 - what should we be ready for?– the EANM perspective

AU - Yakushev, Igor

AU - Verger, Antoine

AU - Brendel, Matthias

AU - Cecchin, Diego

AU - Fernandez, Pablo Aguiar

AU - Fraioli, Francesco

AU - Grimmer, Timo

AU - Tolboom, Nelleke

AU - Traub-Weidinger, Tatjana

AU - Guedj, Eric

AU - Van Weehaeghe, Donatienne

PY - 2025

Y1 - 2025

UR - http://www.scopus.com/inward/record.url?scp=85217260341&partnerID=8YFLogxK

U2 - 10.1007/s00259-025-07066-9

DO - 10.1007/s00259-025-07066-9

M3 - Editorial

C2 - 39789225

AN - SCOPUS:85217260341

SN - 1619-7070

JO - European Journal of Nuclear Medicine and Molecular Imaging

JF - European Journal of Nuclear Medicine and Molecular Imaging

ER -

Lecanemab approval in EU: what should we be ready for?– the EANM perspective

Access to Document

Other files and links

Cite this